Bibliografia UJ CM

1/2
Antonio Palumbo, Roman Hajek, Michel Delforge, Martin Kropff, Maria Teresa Petrucci, John Catalano, Heinz Gisslinger, Wiesław Wiktor Jędrzejczak, Mamia Zodelava, Katja Weisel, Nicola Cascavilla, Genadi Iosava, Michele Cavo, Janusz Kloczko, Joan Blade, Meral Beksac, Ivan Spicka, Torben Plesner, Joergen Radke, Christian Langer, Dina Ben Yehuda, Alessandro Corso, Lindsay Herbein, Zhinuan Yu, Jay Mei, Christian Jacques, Meletios A. Dimopoulos, MM-015 Investigators.
Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
New England Journal of Medicine
2012 : Vol. 366, nr 19, s. 1759-1769, il., bibliogr. 25 poz., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 51.658
Adres url:
Streszczenie w PubMed:
2/2
Susan Branford, Zbigniew Rudzki, Ian Parkinson, Andrew Grigg, Kerry Taylor, John F. Seymour, Simon Durrant, Peter Browett, Anthony P. Schwarer, Chris Arthur, John Catalano, Michael F. Leahy, Robin Filshie, Kenneth Bradstock, Richard Hermann, David Joske, Kevin Lynch, Tim Hughes.
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Blood
2004 : Vol. 103, nr 9, s. 2926-2932, il., bibliogr. 38 poz.
AZ
ORG
AIF
IF: 9.782
Adres url:
Wyświetl ponownie stosując format: